A Bayesian Network Prediction Model for Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma: A Multi‐institutional Study
Qi Li(First Affiliated Hospital of Xi'an Jiaotong University), Zhaohui Tang(Shanxi Agricultural University), Wenlong Zhai(Zhengzhou University), Yinghe Qiu(Second Military Medical University), Yu He(Southern University of Science and Technology), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Zhiqiang Cai(Northwestern Polytechnical University), Xianhai Mao(Hunan Provincial People's Hospital), Zhangjun Cheng(Zhongda Hospital Southeast University), Dong Zhang(Capital Medical University), Jingwei Zhang(Sichuan University), Jingdong Li(Sun Yat-sen University), Hong Wu(Shanghai Tenth People's Hospital), Shubin Si(Northwestern Polytechnical University), Chen Chen(First Affiliated Hospital of Xi'an Jiaotong University), Zhimin Geng(Children's Hospital of Zhejiang University)
Cited by 7
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2021|268